+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 0 - 17Years
All Genders
Healthy Volunteers
ID07860580

Evaluation of Blood Biomarkers Including Alpha-Tectorin and Interleukin-10 in Children With Congenital Hearing Loss Using Cochlear Implants or Hearing Aids

Led by Harran University · Updated on 2026-10-06

120

Participants Needed

1

Research Sites

8 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating the underlying biological mechanisms of congenital sensorineural hearing loss in children. This observational case-control study compares levels of serum alpha-tectorin, interleukin-10 IL-10, and thiol-disulfide homeostasis among children with congenital hearing loss who use cochlear implants, those who use hearing aids, and healthy children with normal hearing. The goal is to better understand these mechanisms and identify potential biomarkers for diagnosis and prognosis. The study involves three groups of children under 18 years one with cochlear implants, one using hearing aids without implants, and a healthy control group. Each participant provides a single blood sample of about 5 mL. The blood is analyzed for serum alpha-tectorin, IL-10, and thiol-disulfide homeostasis parameters using enzyme-linked immunosorbent assay ELISA and spectrophotometric methods. The study collects clinical data, including birth history, device use, and hearing loss degree, to analyze correlations with biomarker levels. Participants undergo audiological testing before enrollment to confirm hearing status. Researchers collect demographic and clinical information and perform blood sample analysis at a single timepoint. The primary outcomes are the serum levels of alpha-tectorin, IL-10, and thiol-disulfide balance. Secondary outcomes include how these biomarkers relate to hearing loss severity. The overall participation involves one blood draw and clinical data collection during the study period ending in April 2027.

CONDITIONS

Brief Title

Alpha-Tectorin, Interleukin-10 and Thiol-Disulfide Homeostasis in Children With Congenital Hearing Loss

Research Team

K

Kemal Özgen, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here